Global 3D Printing in Pharmaceutical Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global 3D Printing in Pharmaceutical market size was valued at USD 70 million in 2022 and is forecast to a readjusted size of USD 115.8 million by 2029 with a CAGR of 7.5% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The traditional pharmaceutical process is complicated, while the 3D printing of drugs has the characteristics of 'rapid prototyping' and the production process is simple. And the production equipment required for 3D printing drugs is much smaller than traditional pharmaceutical equipment, which can realize on-demand production, which has significant advantages in large-scale and small-scale drug production.
This report is a detailed and comprehensive analysis for global 3D Printing in Pharmaceutical market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global 3D Printing in Pharmaceutical market size and forecasts, in consumption value ($ Million), 2018-2029
Global 3D Printing in Pharmaceutical market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global 3D Printing in Pharmaceutical market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global 3D Printing in Pharmaceutical market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for 3D Printing in Pharmaceutical
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global 3D Printing in Pharmaceutical market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Aprecia Pharmaceuticals, Triastek, FabRx, Multiply Labs and Craft Health, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
3D Printing in Pharmaceutical market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe 3D Printing in Pharmaceutical product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of 3D Printing in Pharmaceutical, with revenue, gross margin and global market share of 3D Printing in Pharmaceutical from 2018 to 2023.
Chapter 3, the 3D Printing in Pharmaceutical competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and 3D Printing in Pharmaceutical market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of 3D Printing in Pharmaceutical.
Chapter 13, to describe 3D Printing in Pharmaceutical research findings and conclusion.
The traditional pharmaceutical process is complicated, while the 3D printing of drugs has the characteristics of 'rapid prototyping' and the production process is simple. And the production equipment required for 3D printing drugs is much smaller than traditional pharmaceutical equipment, which can realize on-demand production, which has significant advantages in large-scale and small-scale drug production.
This report is a detailed and comprehensive analysis for global 3D Printing in Pharmaceutical market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global 3D Printing in Pharmaceutical market size and forecasts, in consumption value ($ Million), 2018-2029
Global 3D Printing in Pharmaceutical market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global 3D Printing in Pharmaceutical market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global 3D Printing in Pharmaceutical market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for 3D Printing in Pharmaceutical
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global 3D Printing in Pharmaceutical market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Aprecia Pharmaceuticals, Triastek, FabRx, Multiply Labs and Craft Health, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
3D Printing in Pharmaceutical market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Material Extrusion
- Binder Jetting
- Powder Bed Fusion
- VAT Photopolymerization
- Other
- Mass Production
- Personalized Medicine
- Aprecia Pharmaceuticals
- Triastek
- FabRx
- Multiply Labs
- Craft Health
- DiHeSys
- Merck
- AstraZeneca
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe 3D Printing in Pharmaceutical product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of 3D Printing in Pharmaceutical, with revenue, gross margin and global market share of 3D Printing in Pharmaceutical from 2018 to 2023.
Chapter 3, the 3D Printing in Pharmaceutical competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and 3D Printing in Pharmaceutical market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of 3D Printing in Pharmaceutical.
Chapter 13, to describe 3D Printing in Pharmaceutical research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of 3D Printing in Pharmaceutical
1.2 Market Estimation Caveats and Base Year
1.3 Classification of 3D Printing in Pharmaceutical by Type
1.3.1 Overview: Global 3D Printing in Pharmaceutical Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global 3D Printing in Pharmaceutical Consumption Value Market Share by Type in 2022
1.3.3 Material Extrusion
1.3.4 Binder Jetting
1.3.5 Powder Bed Fusion
1.3.6 VAT Photopolymerization
1.3.7 Other
1.4 Global 3D Printing in Pharmaceutical Market by Application
1.4.1 Overview: Global 3D Printing in Pharmaceutical Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Mass Production
1.4.3 Personalized Medicine
1.5 Global 3D Printing in Pharmaceutical Market Size & Forecast
1.6 Global 3D Printing in Pharmaceutical Market Size and Forecast by Region
1.6.1 Global 3D Printing in Pharmaceutical Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global 3D Printing in Pharmaceutical Market Size by Region, (2018-2029)
1.6.3 North America 3D Printing in Pharmaceutical Market Size and Prospect (2018-2029)
1.6.4 Europe 3D Printing in Pharmaceutical Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific 3D Printing in Pharmaceutical Market Size and Prospect (2018-2029)
1.6.6 South America 3D Printing in Pharmaceutical Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa 3D Printing in Pharmaceutical Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Aprecia Pharmaceuticals
2.1.1 Aprecia Pharmaceuticals Details
2.1.2 Aprecia Pharmaceuticals Major Business
2.1.3 Aprecia Pharmaceuticals 3D Printing in Pharmaceutical Product and Solutions
2.1.4 Aprecia Pharmaceuticals 3D Printing in Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Aprecia Pharmaceuticals Recent Developments and Future Plans
2.2 Triastek
2.2.1 Triastek Details
2.2.2 Triastek Major Business
2.2.3 Triastek 3D Printing in Pharmaceutical Product and Solutions
2.2.4 Triastek 3D Printing in Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Triastek Recent Developments and Future Plans
2.3 FabRx
2.3.1 FabRx Details
2.3.2 FabRx Major Business
2.3.3 FabRx 3D Printing in Pharmaceutical Product and Solutions
2.3.4 FabRx 3D Printing in Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 FabRx Recent Developments and Future Plans
2.4 Multiply Labs
2.4.1 Multiply Labs Details
2.4.2 Multiply Labs Major Business
2.4.3 Multiply Labs 3D Printing in Pharmaceutical Product and Solutions
2.4.4 Multiply Labs 3D Printing in Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Multiply Labs Recent Developments and Future Plans
2.5 Craft Health
2.5.1 Craft Health Details
2.5.2 Craft Health Major Business
2.5.3 Craft Health 3D Printing in Pharmaceutical Product and Solutions
2.5.4 Craft Health 3D Printing in Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Craft Health Recent Developments and Future Plans
2.6 DiHeSys
2.6.1 DiHeSys Details
2.6.2 DiHeSys Major Business
2.6.3 DiHeSys 3D Printing in Pharmaceutical Product and Solutions
2.6.4 DiHeSys 3D Printing in Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 DiHeSys Recent Developments and Future Plans
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business
2.7.3 Merck 3D Printing in Pharmaceutical Product and Solutions
2.7.4 Merck 3D Printing in Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Merck Recent Developments and Future Plans
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business
2.8.3 AstraZeneca 3D Printing in Pharmaceutical Product and Solutions
2.8.4 AstraZeneca 3D Printing in Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 AstraZeneca Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global 3D Printing in Pharmaceutical Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of 3D Printing in Pharmaceutical by Company Revenue
3.2.2 Top 3 3D Printing in Pharmaceutical Players Market Share in 2022
3.2.3 Top 6 3D Printing in Pharmaceutical Players Market Share in 2022
3.3 3D Printing in Pharmaceutical Market: Overall Company Footprint Analysis
3.3.1 3D Printing in Pharmaceutical Market: Region Footprint
3.3.2 3D Printing in Pharmaceutical Market: Company Product Type Footprint
3.3.3 3D Printing in Pharmaceutical Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global 3D Printing in Pharmaceutical Consumption Value and Market Share by Type (2018-2023)
4.2 Global 3D Printing in Pharmaceutical Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global 3D Printing in Pharmaceutical Consumption Value Market Share by Application (2018-2023)
5.2 Global 3D Printing in Pharmaceutical Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America 3D Printing in Pharmaceutical Consumption Value by Type (2018-2029)
6.2 North America 3D Printing in Pharmaceutical Consumption Value by Application (2018-2029)
6.3 North America 3D Printing in Pharmaceutical Market Size by Country
6.3.1 North America 3D Printing in Pharmaceutical Consumption Value by Country (2018-2029)
6.3.2 United States 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
6.3.3 Canada 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
6.3.4 Mexico 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe 3D Printing in Pharmaceutical Consumption Value by Type (2018-2029)
7.2 Europe 3D Printing in Pharmaceutical Consumption Value by Application (2018-2029)
7.3 Europe 3D Printing in Pharmaceutical Market Size by Country
7.3.1 Europe 3D Printing in Pharmaceutical Consumption Value by Country (2018-2029)
7.3.2 Germany 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
7.3.3 France 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
7.3.4 United Kingdom 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
7.3.5 Russia 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
7.3.6 Italy 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific 3D Printing in Pharmaceutical Consumption Value by Type (2018-2029)
8.2 Asia-Pacific 3D Printing in Pharmaceutical Consumption Value by Application (2018-2029)
8.3 Asia-Pacific 3D Printing in Pharmaceutical Market Size by Region
8.3.1 Asia-Pacific 3D Printing in Pharmaceutical Consumption Value by Region (2018-2029)
8.3.2 China 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
8.3.3 Japan 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
8.3.4 South Korea 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
8.3.5 India 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
8.3.7 Australia 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America 3D Printing in Pharmaceutical Consumption Value by Type (2018-2029)
9.2 South America 3D Printing in Pharmaceutical Consumption Value by Application (2018-2029)
9.3 South America 3D Printing in Pharmaceutical Market Size by Country
9.3.1 South America 3D Printing in Pharmaceutical Consumption Value by Country (2018-2029)
9.3.2 Brazil 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
9.3.3 Argentina 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa 3D Printing in Pharmaceutical Consumption Value by Type (2018-2029)
10.2 Middle East & Africa 3D Printing in Pharmaceutical Consumption Value by Application (2018-2029)
10.3 Middle East & Africa 3D Printing in Pharmaceutical Market Size by Country
10.3.1 Middle East & Africa 3D Printing in Pharmaceutical Consumption Value by Country (2018-2029)
10.3.2 Turkey 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
10.3.4 UAE 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 3D Printing in Pharmaceutical Market Drivers
11.2 3D Printing in Pharmaceutical Market Restraints
11.3 3D Printing in Pharmaceutical Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 3D Printing in Pharmaceutical Industry Chain
12.2 3D Printing in Pharmaceutical Upstream Analysis
12.3 3D Printing in Pharmaceutical Midstream Analysis
12.4 3D Printing in Pharmaceutical Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of 3D Printing in Pharmaceutical
1.2 Market Estimation Caveats and Base Year
1.3 Classification of 3D Printing in Pharmaceutical by Type
1.3.1 Overview: Global 3D Printing in Pharmaceutical Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global 3D Printing in Pharmaceutical Consumption Value Market Share by Type in 2022
1.3.3 Material Extrusion
1.3.4 Binder Jetting
1.3.5 Powder Bed Fusion
1.3.6 VAT Photopolymerization
1.3.7 Other
1.4 Global 3D Printing in Pharmaceutical Market by Application
1.4.1 Overview: Global 3D Printing in Pharmaceutical Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Mass Production
1.4.3 Personalized Medicine
1.5 Global 3D Printing in Pharmaceutical Market Size & Forecast
1.6 Global 3D Printing in Pharmaceutical Market Size and Forecast by Region
1.6.1 Global 3D Printing in Pharmaceutical Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global 3D Printing in Pharmaceutical Market Size by Region, (2018-2029)
1.6.3 North America 3D Printing in Pharmaceutical Market Size and Prospect (2018-2029)
1.6.4 Europe 3D Printing in Pharmaceutical Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific 3D Printing in Pharmaceutical Market Size and Prospect (2018-2029)
1.6.6 South America 3D Printing in Pharmaceutical Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa 3D Printing in Pharmaceutical Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Aprecia Pharmaceuticals
2.1.1 Aprecia Pharmaceuticals Details
2.1.2 Aprecia Pharmaceuticals Major Business
2.1.3 Aprecia Pharmaceuticals 3D Printing in Pharmaceutical Product and Solutions
2.1.4 Aprecia Pharmaceuticals 3D Printing in Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Aprecia Pharmaceuticals Recent Developments and Future Plans
2.2 Triastek
2.2.1 Triastek Details
2.2.2 Triastek Major Business
2.2.3 Triastek 3D Printing in Pharmaceutical Product and Solutions
2.2.4 Triastek 3D Printing in Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Triastek Recent Developments and Future Plans
2.3 FabRx
2.3.1 FabRx Details
2.3.2 FabRx Major Business
2.3.3 FabRx 3D Printing in Pharmaceutical Product and Solutions
2.3.4 FabRx 3D Printing in Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 FabRx Recent Developments and Future Plans
2.4 Multiply Labs
2.4.1 Multiply Labs Details
2.4.2 Multiply Labs Major Business
2.4.3 Multiply Labs 3D Printing in Pharmaceutical Product and Solutions
2.4.4 Multiply Labs 3D Printing in Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Multiply Labs Recent Developments and Future Plans
2.5 Craft Health
2.5.1 Craft Health Details
2.5.2 Craft Health Major Business
2.5.3 Craft Health 3D Printing in Pharmaceutical Product and Solutions
2.5.4 Craft Health 3D Printing in Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Craft Health Recent Developments and Future Plans
2.6 DiHeSys
2.6.1 DiHeSys Details
2.6.2 DiHeSys Major Business
2.6.3 DiHeSys 3D Printing in Pharmaceutical Product and Solutions
2.6.4 DiHeSys 3D Printing in Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 DiHeSys Recent Developments and Future Plans
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business
2.7.3 Merck 3D Printing in Pharmaceutical Product and Solutions
2.7.4 Merck 3D Printing in Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Merck Recent Developments and Future Plans
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business
2.8.3 AstraZeneca 3D Printing in Pharmaceutical Product and Solutions
2.8.4 AstraZeneca 3D Printing in Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 AstraZeneca Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global 3D Printing in Pharmaceutical Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of 3D Printing in Pharmaceutical by Company Revenue
3.2.2 Top 3 3D Printing in Pharmaceutical Players Market Share in 2022
3.2.3 Top 6 3D Printing in Pharmaceutical Players Market Share in 2022
3.3 3D Printing in Pharmaceutical Market: Overall Company Footprint Analysis
3.3.1 3D Printing in Pharmaceutical Market: Region Footprint
3.3.2 3D Printing in Pharmaceutical Market: Company Product Type Footprint
3.3.3 3D Printing in Pharmaceutical Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global 3D Printing in Pharmaceutical Consumption Value and Market Share by Type (2018-2023)
4.2 Global 3D Printing in Pharmaceutical Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global 3D Printing in Pharmaceutical Consumption Value Market Share by Application (2018-2023)
5.2 Global 3D Printing in Pharmaceutical Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America 3D Printing in Pharmaceutical Consumption Value by Type (2018-2029)
6.2 North America 3D Printing in Pharmaceutical Consumption Value by Application (2018-2029)
6.3 North America 3D Printing in Pharmaceutical Market Size by Country
6.3.1 North America 3D Printing in Pharmaceutical Consumption Value by Country (2018-2029)
6.3.2 United States 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
6.3.3 Canada 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
6.3.4 Mexico 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe 3D Printing in Pharmaceutical Consumption Value by Type (2018-2029)
7.2 Europe 3D Printing in Pharmaceutical Consumption Value by Application (2018-2029)
7.3 Europe 3D Printing in Pharmaceutical Market Size by Country
7.3.1 Europe 3D Printing in Pharmaceutical Consumption Value by Country (2018-2029)
7.3.2 Germany 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
7.3.3 France 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
7.3.4 United Kingdom 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
7.3.5 Russia 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
7.3.6 Italy 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific 3D Printing in Pharmaceutical Consumption Value by Type (2018-2029)
8.2 Asia-Pacific 3D Printing in Pharmaceutical Consumption Value by Application (2018-2029)
8.3 Asia-Pacific 3D Printing in Pharmaceutical Market Size by Region
8.3.1 Asia-Pacific 3D Printing in Pharmaceutical Consumption Value by Region (2018-2029)
8.3.2 China 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
8.3.3 Japan 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
8.3.4 South Korea 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
8.3.5 India 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
8.3.7 Australia 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America 3D Printing in Pharmaceutical Consumption Value by Type (2018-2029)
9.2 South America 3D Printing in Pharmaceutical Consumption Value by Application (2018-2029)
9.3 South America 3D Printing in Pharmaceutical Market Size by Country
9.3.1 South America 3D Printing in Pharmaceutical Consumption Value by Country (2018-2029)
9.3.2 Brazil 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
9.3.3 Argentina 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa 3D Printing in Pharmaceutical Consumption Value by Type (2018-2029)
10.2 Middle East & Africa 3D Printing in Pharmaceutical Consumption Value by Application (2018-2029)
10.3 Middle East & Africa 3D Printing in Pharmaceutical Market Size by Country
10.3.1 Middle East & Africa 3D Printing in Pharmaceutical Consumption Value by Country (2018-2029)
10.3.2 Turkey 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
10.3.4 UAE 3D Printing in Pharmaceutical Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 3D Printing in Pharmaceutical Market Drivers
11.2 3D Printing in Pharmaceutical Market Restraints
11.3 3D Printing in Pharmaceutical Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 3D Printing in Pharmaceutical Industry Chain
12.2 3D Printing in Pharmaceutical Upstream Analysis
12.3 3D Printing in Pharmaceutical Midstream Analysis
12.4 3D Printing in Pharmaceutical Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global 3D Printing in Pharmaceutical Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global 3D Printing in Pharmaceutical Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global 3D Printing in Pharmaceutical Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global 3D Printing in Pharmaceutical Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Aprecia Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 6. Aprecia Pharmaceuticals Major Business
Table 7. Aprecia Pharmaceuticals 3D Printing in Pharmaceutical Product and Solutions
Table 8. Aprecia Pharmaceuticals 3D Printing in Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Aprecia Pharmaceuticals Recent Developments and Future Plans
Table 10. Triastek Company Information, Head Office, and Major Competitors
Table 11. Triastek Major Business
Table 12. Triastek 3D Printing in Pharmaceutical Product and Solutions
Table 13. Triastek 3D Printing in Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Triastek Recent Developments and Future Plans
Table 15. FabRx Company Information, Head Office, and Major Competitors
Table 16. FabRx Major Business
Table 17. FabRx 3D Printing in Pharmaceutical Product and Solutions
Table 18. FabRx 3D Printing in Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. FabRx Recent Developments and Future Plans
Table 20. Multiply Labs Company Information, Head Office, and Major Competitors
Table 21. Multiply Labs Major Business
Table 22. Multiply Labs 3D Printing in Pharmaceutical Product and Solutions
Table 23. Multiply Labs 3D Printing in Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Multiply Labs Recent Developments and Future Plans
Table 25. Craft Health Company Information, Head Office, and Major Competitors
Table 26. Craft Health Major Business
Table 27. Craft Health 3D Printing in Pharmaceutical Product and Solutions
Table 28. Craft Health 3D Printing in Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Craft Health Recent Developments and Future Plans
Table 30. DiHeSys Company Information, Head Office, and Major Competitors
Table 31. DiHeSys Major Business
Table 32. DiHeSys 3D Printing in Pharmaceutical Product and Solutions
Table 33. DiHeSys 3D Printing in Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. DiHeSys Recent Developments and Future Plans
Table 35. Merck Company Information, Head Office, and Major Competitors
Table 36. Merck Major Business
Table 37. Merck 3D Printing in Pharmaceutical Product and Solutions
Table 38. Merck 3D Printing in Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Merck Recent Developments and Future Plans
Table 40. AstraZeneca Company Information, Head Office, and Major Competitors
Table 41. AstraZeneca Major Business
Table 42. AstraZeneca 3D Printing in Pharmaceutical Product and Solutions
Table 43. AstraZeneca 3D Printing in Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. AstraZeneca Recent Developments and Future Plans
Table 45. Global 3D Printing in Pharmaceutical Revenue (USD Million) by Players (2018-2023)
Table 46. Global 3D Printing in Pharmaceutical Revenue Share by Players (2018-2023)
Table 47. Breakdown of 3D Printing in Pharmaceutical by Company Type (Tier 1, Tier 2, and Tier 3)
Table 48. Market Position of Players in 3D Printing in Pharmaceutical, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 49. Head Office of Key 3D Printing in Pharmaceutical Players
Table 50. 3D Printing in Pharmaceutical Market: Company Product Type Footprint
Table 51. 3D Printing in Pharmaceutical Market: Company Product Application Footprint
Table 52. 3D Printing in Pharmaceutical New Market Entrants and Barriers to Market Entry
Table 53. 3D Printing in Pharmaceutical Mergers, Acquisition, Agreements, and Collaborations
Table 54. Global 3D Printing in Pharmaceutical Consumption Value (USD Million) by Type (2018-2023)
Table 55. Global 3D Printing in Pharmaceutical Consumption Value Share by Type (2018-2023)
Table 56. Global 3D Printing in Pharmaceutical Consumption Value Forecast by Type (2024-2029)
Table 57. Global 3D Printing in Pharmaceutical Consumption Value by Application (2018-2023)
Table 58. Global 3D Printing in Pharmaceutical Consumption Value Forecast by Application (2024-2029)
Table 59. North America 3D Printing in Pharmaceutical Consumption Value by Type (2018-2023) & (USD Million)
Table 60. North America 3D Printing in Pharmaceutical Consumption Value by Type (2024-2029) & (USD Million)
Table 61. North America 3D Printing in Pharmaceutical Consumption Value by Application (2018-2023) & (USD Million)
Table 62. North America 3D Printing in Pharmaceutical Consumption Value by Application (2024-2029) & (USD Million)
Table 63. North America 3D Printing in Pharmaceutical Consumption Value by Country (2018-2023) & (USD Million)
Table 64. North America 3D Printing in Pharmaceutical Consumption Value by Country (2024-2029) & (USD Million)
Table 65. Europe 3D Printing in Pharmaceutical Consumption Value by Type (2018-2023) & (USD Million)
Table 66. Europe 3D Printing in Pharmaceutical Consumption Value by Type (2024-2029) & (USD Million)
Table 67. Europe 3D Printing in Pharmaceutical Consumption Value by Application (2018-2023) & (USD Million)
Table 68. Europe 3D Printing in Pharmaceutical Consumption Value by Application (2024-2029) & (USD Million)
Table 69. Europe 3D Printing in Pharmaceutical Consumption Value by Country (2018-2023) & (USD Million)
Table 70. Europe 3D Printing in Pharmaceutical Consumption Value by Country (2024-2029) & (USD Million)
Table 71. Asia-Pacific 3D Printing in Pharmaceutical Consumption Value by Type (2018-2023) & (USD Million)
Table 72. Asia-Pacific 3D Printing in Pharmaceutical Consumption Value by Type (2024-2029) & (USD Million)
Table 73. Asia-Pacific 3D Printing in Pharmaceutical Consumption Value by Application (2018-2023) & (USD Million)
Table 74. Asia-Pacific 3D Printing in Pharmaceutical Consumption Value by Application (2024-2029) & (USD Million)
Table 75. Asia-Pacific 3D Printing in Pharmaceutical Consumption Value by Region (2018-2023) & (USD Million)
Table 76. Asia-Pacific 3D Printing in Pharmaceutical Consumption Value by Region (2024-2029) & (USD Million)
Table 77. South America 3D Printing in Pharmaceutical Consumption Value by Type (2018-2023) & (USD Million)
Table 78. South America 3D Printing in Pharmaceutical Consumption Value by Type (2024-2029) & (USD Million)
Table 79. South America 3D Printing in Pharmaceutical Consumption Value by Application (2018-2023) & (USD Million)
Table 80. South America 3D Printing in Pharmaceutical Consumption Value by Application (2024-2029) & (USD Million)
Table 81. South America 3D Printing in Pharmaceutical Consumption Value by Country (2018-2023) & (USD Million)
Table 82. South America 3D Printing in Pharmaceutical Consumption Value by Country (2024-2029) & (USD Million)
Table 83. Middle East & Africa 3D Printing in Pharmaceutical Consumption Value by Type (2018-2023) & (USD Million)
Table 84. Middle East & Africa 3D Printing in Pharmaceutical Consumption Value by Type (2024-2029) & (USD Million)
Table 85. Middle East & Africa 3D Printing in Pharmaceutical Consumption Value by Application (2018-2023) & (USD Million)
Table 86. Middle East & Africa 3D Printing in Pharmaceutical Consumption Value by Application (2024-2029) & (USD Million)
Table 87. Middle East & Africa 3D Printing in Pharmaceutical Consumption Value by Country (2018-2023) & (USD Million)
Table 88. Middle East & Africa 3D Printing in Pharmaceutical Consumption Value by Country (2024-2029) & (USD Million)
Table 89. 3D Printing in Pharmaceutical Raw Material
Table 90. Key Suppliers of 3D Printing in Pharmaceutical Raw Materials
Table 1. Global 3D Printing in Pharmaceutical Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global 3D Printing in Pharmaceutical Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global 3D Printing in Pharmaceutical Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global 3D Printing in Pharmaceutical Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Aprecia Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 6. Aprecia Pharmaceuticals Major Business
Table 7. Aprecia Pharmaceuticals 3D Printing in Pharmaceutical Product and Solutions
Table 8. Aprecia Pharmaceuticals 3D Printing in Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Aprecia Pharmaceuticals Recent Developments and Future Plans
Table 10. Triastek Company Information, Head Office, and Major Competitors
Table 11. Triastek Major Business
Table 12. Triastek 3D Printing in Pharmaceutical Product and Solutions
Table 13. Triastek 3D Printing in Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Triastek Recent Developments and Future Plans
Table 15. FabRx Company Information, Head Office, and Major Competitors
Table 16. FabRx Major Business
Table 17. FabRx 3D Printing in Pharmaceutical Product and Solutions
Table 18. FabRx 3D Printing in Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. FabRx Recent Developments and Future Plans
Table 20. Multiply Labs Company Information, Head Office, and Major Competitors
Table 21. Multiply Labs Major Business
Table 22. Multiply Labs 3D Printing in Pharmaceutical Product and Solutions
Table 23. Multiply Labs 3D Printing in Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Multiply Labs Recent Developments and Future Plans
Table 25. Craft Health Company Information, Head Office, and Major Competitors
Table 26. Craft Health Major Business
Table 27. Craft Health 3D Printing in Pharmaceutical Product and Solutions
Table 28. Craft Health 3D Printing in Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Craft Health Recent Developments and Future Plans
Table 30. DiHeSys Company Information, Head Office, and Major Competitors
Table 31. DiHeSys Major Business
Table 32. DiHeSys 3D Printing in Pharmaceutical Product and Solutions
Table 33. DiHeSys 3D Printing in Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. DiHeSys Recent Developments and Future Plans
Table 35. Merck Company Information, Head Office, and Major Competitors
Table 36. Merck Major Business
Table 37. Merck 3D Printing in Pharmaceutical Product and Solutions
Table 38. Merck 3D Printing in Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Merck Recent Developments and Future Plans
Table 40. AstraZeneca Company Information, Head Office, and Major Competitors
Table 41. AstraZeneca Major Business
Table 42. AstraZeneca 3D Printing in Pharmaceutical Product and Solutions
Table 43. AstraZeneca 3D Printing in Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. AstraZeneca Recent Developments and Future Plans
Table 45. Global 3D Printing in Pharmaceutical Revenue (USD Million) by Players (2018-2023)
Table 46. Global 3D Printing in Pharmaceutical Revenue Share by Players (2018-2023)
Table 47. Breakdown of 3D Printing in Pharmaceutical by Company Type (Tier 1, Tier 2, and Tier 3)
Table 48. Market Position of Players in 3D Printing in Pharmaceutical, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 49. Head Office of Key 3D Printing in Pharmaceutical Players
Table 50. 3D Printing in Pharmaceutical Market: Company Product Type Footprint
Table 51. 3D Printing in Pharmaceutical Market: Company Product Application Footprint
Table 52. 3D Printing in Pharmaceutical New Market Entrants and Barriers to Market Entry
Table 53. 3D Printing in Pharmaceutical Mergers, Acquisition, Agreements, and Collaborations
Table 54. Global 3D Printing in Pharmaceutical Consumption Value (USD Million) by Type (2018-2023)
Table 55. Global 3D Printing in Pharmaceutical Consumption Value Share by Type (2018-2023)
Table 56. Global 3D Printing in Pharmaceutical Consumption Value Forecast by Type (2024-2029)
Table 57. Global 3D Printing in Pharmaceutical Consumption Value by Application (2018-2023)
Table 58. Global 3D Printing in Pharmaceutical Consumption Value Forecast by Application (2024-2029)
Table 59. North America 3D Printing in Pharmaceutical Consumption Value by Type (2018-2023) & (USD Million)
Table 60. North America 3D Printing in Pharmaceutical Consumption Value by Type (2024-2029) & (USD Million)
Table 61. North America 3D Printing in Pharmaceutical Consumption Value by Application (2018-2023) & (USD Million)
Table 62. North America 3D Printing in Pharmaceutical Consumption Value by Application (2024-2029) & (USD Million)
Table 63. North America 3D Printing in Pharmaceutical Consumption Value by Country (2018-2023) & (USD Million)
Table 64. North America 3D Printing in Pharmaceutical Consumption Value by Country (2024-2029) & (USD Million)
Table 65. Europe 3D Printing in Pharmaceutical Consumption Value by Type (2018-2023) & (USD Million)
Table 66. Europe 3D Printing in Pharmaceutical Consumption Value by Type (2024-2029) & (USD Million)
Table 67. Europe 3D Printing in Pharmaceutical Consumption Value by Application (2018-2023) & (USD Million)
Table 68. Europe 3D Printing in Pharmaceutical Consumption Value by Application (2024-2029) & (USD Million)
Table 69. Europe 3D Printing in Pharmaceutical Consumption Value by Country (2018-2023) & (USD Million)
Table 70. Europe 3D Printing in Pharmaceutical Consumption Value by Country (2024-2029) & (USD Million)
Table 71. Asia-Pacific 3D Printing in Pharmaceutical Consumption Value by Type (2018-2023) & (USD Million)
Table 72. Asia-Pacific 3D Printing in Pharmaceutical Consumption Value by Type (2024-2029) & (USD Million)
Table 73. Asia-Pacific 3D Printing in Pharmaceutical Consumption Value by Application (2018-2023) & (USD Million)
Table 74. Asia-Pacific 3D Printing in Pharmaceutical Consumption Value by Application (2024-2029) & (USD Million)
Table 75. Asia-Pacific 3D Printing in Pharmaceutical Consumption Value by Region (2018-2023) & (USD Million)
Table 76. Asia-Pacific 3D Printing in Pharmaceutical Consumption Value by Region (2024-2029) & (USD Million)
Table 77. South America 3D Printing in Pharmaceutical Consumption Value by Type (2018-2023) & (USD Million)
Table 78. South America 3D Printing in Pharmaceutical Consumption Value by Type (2024-2029) & (USD Million)
Table 79. South America 3D Printing in Pharmaceutical Consumption Value by Application (2018-2023) & (USD Million)
Table 80. South America 3D Printing in Pharmaceutical Consumption Value by Application (2024-2029) & (USD Million)
Table 81. South America 3D Printing in Pharmaceutical Consumption Value by Country (2018-2023) & (USD Million)
Table 82. South America 3D Printing in Pharmaceutical Consumption Value by Country (2024-2029) & (USD Million)
Table 83. Middle East & Africa 3D Printing in Pharmaceutical Consumption Value by Type (2018-2023) & (USD Million)
Table 84. Middle East & Africa 3D Printing in Pharmaceutical Consumption Value by Type (2024-2029) & (USD Million)
Table 85. Middle East & Africa 3D Printing in Pharmaceutical Consumption Value by Application (2018-2023) & (USD Million)
Table 86. Middle East & Africa 3D Printing in Pharmaceutical Consumption Value by Application (2024-2029) & (USD Million)
Table 87. Middle East & Africa 3D Printing in Pharmaceutical Consumption Value by Country (2018-2023) & (USD Million)
Table 88. Middle East & Africa 3D Printing in Pharmaceutical Consumption Value by Country (2024-2029) & (USD Million)
Table 89. 3D Printing in Pharmaceutical Raw Material
Table 90. Key Suppliers of 3D Printing in Pharmaceutical Raw Materials
LIST OF FIGURES
Figure 1. 3D Printing in Pharmaceutical Picture
Figure 2. Global 3D Printing in Pharmaceutical Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global 3D Printing in Pharmaceutical Consumption Value Market Share by Type in 2022
Figure 4. Material Extrusion
Figure 5. Binder Jetting
Figure 6. Powder Bed Fusion
Figure 7. VAT Photopolymerization
Figure 8. Other
Figure 9. Global 3D Printing in Pharmaceutical Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 10. 3D Printing in Pharmaceutical Consumption Value Market Share by Application in 2022
Figure 11. Mass Production Picture
Figure 12. Personalized Medicine Picture
Figure 13. Global 3D Printing in Pharmaceutical Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global 3D Printing in Pharmaceutical Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Market 3D Printing in Pharmaceutical Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 16. Global 3D Printing in Pharmaceutical Consumption Value Market Share by Region (2018-2029)
Figure 17. Global 3D Printing in Pharmaceutical Consumption Value Market Share by Region in 2022
Figure 18. North America 3D Printing in Pharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe 3D Printing in Pharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 20. Asia-Pacific 3D Printing in Pharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 21. South America 3D Printing in Pharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 22. Middle East and Africa 3D Printing in Pharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 23. Global 3D Printing in Pharmaceutical Revenue Share by Players in 2022
Figure 24. 3D Printing in Pharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 25. Global Top 3 Players 3D Printing in Pharmaceutical Market Share in 2022
Figure 26. Global Top 6 Players 3D Printing in Pharmaceutical Market Share in 2022
Figure 27. Global 3D Printing in Pharmaceutical Consumption Value Share by Type (2018-2023)
Figure 28. Global 3D Printing in Pharmaceutical Market Share Forecast by Type (2024-2029)
Figure 29. Global 3D Printing in Pharmaceutical Consumption Value Share by Application (2018-2023)
Figure 30. Global 3D Printing in Pharmaceutical Market Share Forecast by Application (2024-2029)
Figure 31. North America 3D Printing in Pharmaceutical Consumption Value Market Share by Type (2018-2029)
Figure 32. North America 3D Printing in Pharmaceutical Consumption Value Market Share by Application (2018-2029)
Figure 33. North America 3D Printing in Pharmaceutical Consumption Value Market Share by Country (2018-2029)
Figure 34. United States 3D Printing in Pharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 35. Canada 3D Printing in Pharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 36. Mexico 3D Printing in Pharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 37. Europe 3D Printing in Pharmaceutical Consumption Value Market Share by Type (2018-2029)
Figure 38. Europe 3D Printing in Pharmaceutical Consumption Value Market Share by Application (2018-2029)
Figure 39. Europe 3D Printing in Pharmaceutical Consumption Value Market Share by Country (2018-2029)
Figure 40. Germany 3D Printing in Pharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 41. France 3D Printing in Pharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 42. United Kingdom 3D Printing in Pharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 43. Russia 3D Printing in Pharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 44. Italy 3D Printing in Pharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 45. Asia-Pacific 3D Printing in Pharmaceutical Consumption Value Market Share by Type (2018-2029)
Figure 46. Asia-Pacific 3D Printing in Pharmaceutical Consumption Value Market Share by Application (2018-2029)
Figure 47. Asia-Pacific 3D Printing in Pharmaceutical Consumption Value Market Share by Region (2018-2029)
Figure 48. China 3D Printing in Pharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 49. Japan 3D Printing in Pharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 50. South Korea 3D Printing in Pharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 51. India 3D Printing in Pharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 52. Southeast Asia 3D Printing in Pharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 53. Australia 3D Printing in Pharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 54. South America 3D Printing in Pharmaceutical Consumption Value Market Share by Type (2018-2029)
Figure 55. South America 3D Printing in Pharmaceutical Consumption Value Market Share by Application (2018-2029)
Figure 56. South America 3D Printing in Pharmaceutical Consumption Value Market Share by Country (2018-2029)
Figure 57. Brazil 3D Printing in Pharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 58. Argentina 3D Printing in Pharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 59. Middle East and Africa 3D Printing in Pharmaceutical Consumption Value Market Share by Type (2018-2029)
Figure 60. Middle East and Africa 3D Printing in Pharmaceutical Consumption Value Market Share by Application (2018-2029)
Figure 61. Middle East and Africa 3D Printing in Pharmaceutical Consumption Value Market Share by Country (2018-2029)
Figure 62. Turkey 3D Printing in Pharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 63. Saudi Arabia 3D Printing in Pharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 64. UAE 3D Printing in Pharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 65. 3D Printing in Pharmaceutical Market Drivers
Figure 66. 3D Printing in Pharmaceutical Market Restraints
Figure 67. 3D Printing in Pharmaceutical Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of 3D Printing in Pharmaceutical in 2022
Figure 70. Manufacturing Process Analysis of 3D Printing in Pharmaceutical
Figure 71. 3D Printing in Pharmaceutical Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Figure 1. 3D Printing in Pharmaceutical Picture
Figure 2. Global 3D Printing in Pharmaceutical Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global 3D Printing in Pharmaceutical Consumption Value Market Share by Type in 2022
Figure 4. Material Extrusion
Figure 5. Binder Jetting
Figure 6. Powder Bed Fusion
Figure 7. VAT Photopolymerization
Figure 8. Other
Figure 9. Global 3D Printing in Pharmaceutical Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 10. 3D Printing in Pharmaceutical Consumption Value Market Share by Application in 2022
Figure 11. Mass Production Picture
Figure 12. Personalized Medicine Picture
Figure 13. Global 3D Printing in Pharmaceutical Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global 3D Printing in Pharmaceutical Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Market 3D Printing in Pharmaceutical Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 16. Global 3D Printing in Pharmaceutical Consumption Value Market Share by Region (2018-2029)
Figure 17. Global 3D Printing in Pharmaceutical Consumption Value Market Share by Region in 2022
Figure 18. North America 3D Printing in Pharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe 3D Printing in Pharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 20. Asia-Pacific 3D Printing in Pharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 21. South America 3D Printing in Pharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 22. Middle East and Africa 3D Printing in Pharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 23. Global 3D Printing in Pharmaceutical Revenue Share by Players in 2022
Figure 24. 3D Printing in Pharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 25. Global Top 3 Players 3D Printing in Pharmaceutical Market Share in 2022
Figure 26. Global Top 6 Players 3D Printing in Pharmaceutical Market Share in 2022
Figure 27. Global 3D Printing in Pharmaceutical Consumption Value Share by Type (2018-2023)
Figure 28. Global 3D Printing in Pharmaceutical Market Share Forecast by Type (2024-2029)
Figure 29. Global 3D Printing in Pharmaceutical Consumption Value Share by Application (2018-2023)
Figure 30. Global 3D Printing in Pharmaceutical Market Share Forecast by Application (2024-2029)
Figure 31. North America 3D Printing in Pharmaceutical Consumption Value Market Share by Type (2018-2029)
Figure 32. North America 3D Printing in Pharmaceutical Consumption Value Market Share by Application (2018-2029)
Figure 33. North America 3D Printing in Pharmaceutical Consumption Value Market Share by Country (2018-2029)
Figure 34. United States 3D Printing in Pharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 35. Canada 3D Printing in Pharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 36. Mexico 3D Printing in Pharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 37. Europe 3D Printing in Pharmaceutical Consumption Value Market Share by Type (2018-2029)
Figure 38. Europe 3D Printing in Pharmaceutical Consumption Value Market Share by Application (2018-2029)
Figure 39. Europe 3D Printing in Pharmaceutical Consumption Value Market Share by Country (2018-2029)
Figure 40. Germany 3D Printing in Pharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 41. France 3D Printing in Pharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 42. United Kingdom 3D Printing in Pharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 43. Russia 3D Printing in Pharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 44. Italy 3D Printing in Pharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 45. Asia-Pacific 3D Printing in Pharmaceutical Consumption Value Market Share by Type (2018-2029)
Figure 46. Asia-Pacific 3D Printing in Pharmaceutical Consumption Value Market Share by Application (2018-2029)
Figure 47. Asia-Pacific 3D Printing in Pharmaceutical Consumption Value Market Share by Region (2018-2029)
Figure 48. China 3D Printing in Pharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 49. Japan 3D Printing in Pharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 50. South Korea 3D Printing in Pharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 51. India 3D Printing in Pharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 52. Southeast Asia 3D Printing in Pharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 53. Australia 3D Printing in Pharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 54. South America 3D Printing in Pharmaceutical Consumption Value Market Share by Type (2018-2029)
Figure 55. South America 3D Printing in Pharmaceutical Consumption Value Market Share by Application (2018-2029)
Figure 56. South America 3D Printing in Pharmaceutical Consumption Value Market Share by Country (2018-2029)
Figure 57. Brazil 3D Printing in Pharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 58. Argentina 3D Printing in Pharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 59. Middle East and Africa 3D Printing in Pharmaceutical Consumption Value Market Share by Type (2018-2029)
Figure 60. Middle East and Africa 3D Printing in Pharmaceutical Consumption Value Market Share by Application (2018-2029)
Figure 61. Middle East and Africa 3D Printing in Pharmaceutical Consumption Value Market Share by Country (2018-2029)
Figure 62. Turkey 3D Printing in Pharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 63. Saudi Arabia 3D Printing in Pharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 64. UAE 3D Printing in Pharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 65. 3D Printing in Pharmaceutical Market Drivers
Figure 66. 3D Printing in Pharmaceutical Market Restraints
Figure 67. 3D Printing in Pharmaceutical Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of 3D Printing in Pharmaceutical in 2022
Figure 70. Manufacturing Process Analysis of 3D Printing in Pharmaceutical
Figure 71. 3D Printing in Pharmaceutical Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
